The anti-IgE approach to asthma treatment has several advantages, including concomitant treatment of other IgE-mediated diseases and a favorable side-effect profile regardless of the type of allergic sensitisation [28-34,41-44,48]. This evidence concerns the gene IGHE and glycogen storage disease VI.